Skip to content

Clinical trials

Phase 1 Endometrial Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 1 Country / region: United States Clear all

187 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20015
20021
20032
20044
20052
20062
20072
20084
20092
20106
20119
20122
20132
20146
20155
20167
20175
20187
201913
20209
202114
202210
202315
202415
202517
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed74
Recruiting46
Terminated30
Active, not recruiting23
Unknown status5
Withdrawn4
Not yet recruiting3
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
M.D. Anderson Cancer Center7
UNC Lineberger Comprehensive Cancer Center6
Eli Lilly and Company5
Memorial Sloan Kettering Cancer Center5
Washington University School of Medicine4
Xencor, Inc.4
Dana-Farber Cancer Institute3
GlaxoSmithKline3
Mayo Clinic3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms187
Ovarian Neoplasms92
Breast Neoplasms64
Uterine Cervical Neoplasms63
Carcinoma, Non-Small-Cell Lung60
Stomach Neoplasms50
Colorectal Neoplasms40
Fallopian Tube Neoplasms38
Neoplasms37
Triple Negative Breast Neoplasms37

Trials

Showing 1 to 25 of 187. Each trial links to its page on Pharma Observatory.

87 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.